Skip to main content
FinSpry Logo
FinSpry
RCKT logo
RCKT
(NASDAQ)
Rocket Pharmaceuticals, Inc.
$3.28-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Rocket Pharmaceuticals, Inc. (RCKT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Rocket Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$11.80
↑ 259.76% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RCKT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jason Zemansky
BofA Securities
BuyMaintains
$10.00
Jason Zemansky
BofA Securities
BuyReiterates
$9.00 → $10.00
Tara Bancroft
TD Cowen
HoldMaintains
-
Geulah Livshits
Chardan Capital
BuyReiterates
$11.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$10.00
Patrick Dolezal
LifeSci Capital
BuyReiterates
$12.00
Yun Zhong
Wedbush
BuyReiterates
$16.00
Gil Blum
Needham
HoldMaintains
-
Whitney Ijem
Canaccord Genuity
BuyMaintains
$10.00

Frequently Asked Questions

What is the analyst consensus rating for RCKT?

The analyst consensus rating for RCKT is "Buy" based on 7 analyst recommendations.

What is the average price target for RCKT?

The average 12-month price target for RCKT is $11.80, representing an upside of 259.8% from the current price of $3.28.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.